SALEM INVESTMENT COUNSELORS INC - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.

Quarter-by-quarter ownership
SALEM INVESTMENT COUNSELORS INC ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q1 2023$21,934
+12.9%
6780.0%0.00%0.0%
Q4 2022$19,431
-7.5%
678
-22.0%
0.00%0.0%
Q3 2022$21,000
-22.2%
869
-10.3%
0.00%0.0%
Q2 2022$27,000
-27.0%
9690.0%0.00%0.0%
Q1 2022$37,000
-50.7%
969
-58.5%
0.00%
-66.7%
Q4 2021$75,0002,3360.00%
Other shareholders
VANECK VECTORS ETF TR shareholders Q1 2022
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$19,873,03580.92%
New Harbor Financial Group, LLC 1,680,752$45,229,03314.96%
TORQ CAPITAL MANAGEMENT (HK) Ltd 139,000$3,740,4909.95%
Vanderbilt University 1,360,540$36,612,1319.45%
Eschler Asset Management LLP 300,000$8,073,0009.42%
New Harbor Financial Group, LLC 1,027,300$27,644,6439.15%
Guild Investment Management, Inc. 139,333$3,749,4546.28%
Monaco Asset Management SAM 750,000$20,182,5005.98%
STRATEGIC INVESTMENT MANAGEMENT, LLC 132,460$3,867,8324.74%
PCG Wealth Advisors, LLC 264,614$7,120,7824.67%
View complete list of VANECK VECTORS ETF TR shareholders